We are the right partner for

Transcription

1

2 We are the right partner for all kind of transactions in the Pharma / Healthcare Industry Mergers & Acquisitions (share deals) Divestments and acquisitions of companies Specialization in divestment of production sites Strategic alliances (joint ventures) Strategic Consulting Valuation for financial institutions Portfolio management Marketing & sales strategies Change management Executive Search Post Merger Integration Core Business Areas Product Transactions (asset deals) Divestments of products / brands / portfolios Acquisitions of products / brands / portfolios Partnering Licensing out (worldwide) Licensing in (worldwide) Supply & distribution agreements Business planning 2

3 Why we are the right partner for you! 1 1 Expertise 25 years in-depth expertise in all aspects of Pharma M&A, Product transactions, Partnering and Strategic consulting Advisors Fully involved Senior Advisors with executive management expertise in the pharmaceutical industry 5 5 Success Target oriented, efficient, intelligent and successful project management More than 500 transactions closed 5 5 STEPS TO SUCCESS Global Unique global database and comprehensive network of healthcare and M&A experts 4 4 Experience Broad experience in cross-bordertransactions worldwide 3

4 Our core team KLAUS MANLIK Managing Partner MATHIAS KÄSEBIER Senior Director ULRIKE DÄXL Portfolio Analyst / Consultant Long term expertise in numerous national and international projects. Specialist in M&A and product transfers. Broad marketing & sales and business development experience in leading positions in big pharma and medium-sized enterprises. Long term experience in operative and strategic business development. Specialist in M&A and product divestiture processes and growth strategies. Previous industry experience especially in OTC/Wellness/Phyto included: CEO of Heel Inc., Albuquerque, USA. Director of Consumer Health Americas, Boehringer Ingelheim, International Marketing Director Natural Health. Expert knowledge of general and comparative financial analysis. Specialist in establishing growth strategies, e.g. creating shareholder value. Previous industry experience as Senior Portfolio Manager/ Analyst for healthcare stocks (pharma, medtech & biotech) in several asset management companies, including in-depth analysis and stock picking strategies. 4

5 Our international team Headquarter Germany, Starnberg Dr. Renate Moser Regional Associate Austria, Wien (Austria) Thomas Merrifield Territorial Associate North America incl. Canada, South Carolina Dr. Kah Foo Territorial Associate Asia (incl. SEA,, Japan, Korea), Singapore Volker Adam Regional Associate Mexico, Mexico City (Mexico) Yornick Hurtado Territorial Associate Central America and Venezuela, Miami (USA) Lukas Radtke Regional Associate Brazil and Mercosur, Sao Paulo (Brazil) Arun Kumbhat Territorial Associate India Pablo Faglioli Territorial Associate Argentina Dr. Diether Wienbeck Territorial Associate CEE, Russia, CIS 5

6 Rx Nutraceuticals Generics Dermacosmetics OTC Diagnostics Pharmaceutical production OUR KNOW-HOW Medtech Biotech R&D Licensing Projects Hospitals Veterinary 6

7 Our Services for Mergers & Acquisitions, Product Transactions and Partnering Market Intelligence Valuation of Business Due Diligence Guidance Post Merger Integration Strategic Planning Fact Sheet / Info Memo Face-to-face meetings Post Transaction Implementation Project Management Identification of Candidates Negotiations Process Monitoring 7

8 Strategic Consulting with a broad range of services to meet strategic challenges Strategy analysis Strategy developement Strategy planning Implementation Monitoring Company strategy Organizational change Portfolio management Sales strategy Marketing strategy Valuation of business opportunities 8

9 companies and individuals ALL OVER THE WORLD

10 Proprietary global database BANNERT MANLIK s unique proprietary global database includes more than 22,000 companies and more than 50,000 individuals, which guarantees fast-paced and success-oriented project management 43% Europe, incl. Germany & CEE 30% Central & South America 9% USA 5% Asia 8% Russia 3% Mena 2% ROW 10

11 Public information Private information Proprietary global database All information has been collected and developed over the last 25 years Company coordinates Contact data of key persons, e.g. management and BD Company type: Pharma, Biotech, PE Start-up, CMO, CRO etc. Therapeutic areas, further classified by ATC Code Market segments: Rx, OTC, OTx, Medtech, etc. Business areas: ethical drugs, generics, food supplements, etc. Classification of production facilities by pharmaceutical forms, packaging materials, etc. Financial details Current status and future strategic directions R&D pipeline Openness to cooperation, joint ventures, acquisitions, etc. Successor regulations 11

12 Proprietary global database Precise and quick customized targeting to identify and match potential candidates Final Candidates Core List Candidates: confirmed indication of interest Short-list Candidates: Indication of interest after teaser Long-list Candidates: Potential candidates after analysis Universe All relevant preliminary candidates 12

13 A selection of successfully completed projects (M&A) 13

14 A selection of successfully completed projects (product transactions & partnering) 14

15 Our references In more than twenty-five years of business, BANNERT MANLIK has successfully conducted more than 500 national and international transactions, ranging from 1m to 100m USD (sales value) 15

16 About Bannert Manlik Consultants Since 1991, BANNERT MANLIK is one of the leading international strategic consulting firms for the pharmaceutical and healthcare industries. We assist our clients throughout the entire M&A process, provide portfolio management strategies, as well as support in the realization of international growth and other strategic goals. Our Office Bannert Manlik Consultants GmbH Maximilianstrasse 4e Starnberg, Germany Tel: Fax: